We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

MINDRAY In-Vitro Diagnostics

As a global leader in in-vitro diagnostics, Mindray provides a wide range of efficient, reliable IVD solutions for la... read more Featured Products: More products

Download Mobile App





Mindray Medical Unveils Chemiluminescence Immunoassay System at AACC 2018

By Theresa Herman, Regional Director
Posted on 27 Mar 2019
Mindray Medical (Shenzhen, China), a leading provider of IVD devices and reagents with core business in hematology, clinical chemistry and CLIA, showcased one of the world's smallest, fully automated chemiluminescence immunoassay analyzers at AACC, the world’s largest exposition for clinical laboratory products and services. More...
This year’s annual event was held in Chicago, Illinois, USA, from July 31 to August 2.

Mindray’s solutions cover diverse laboratory needs worldwide. The company offers industry leading hematology analyzers and scalable automation lines, wide-range chemistry analyzers with traceable reagents, immunoassay systems with full assays, and products in flow cytometry, HPLC analysis, coagulation, etc.

At AACC, Mindray also unveiled the CL900i – a fully automated benchtop chemiluminescence immunoassay system with industry-leading small size that helps maximize laboratory space. With its industry-leading small footprint, fast throughput of 180 tests per hour and zero user maintenance, the CL900i benchtop analyzer provides easy and quality CLIA testing without taking up valuable laboratory floor space. The CL900i offers a broad range of testing results, 50 positions for reagents and 50 positions for samples, making it ideal for small laboratories looking for savings in cost as well as space and having high standards of quality.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
All-in-One Molecular System
AIO M160
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Acute lymphoblastic leukemia in children and young people requires careful relapse risk assessment as treatment expands beyond standard chemotherapy. (Image Credit: Shutterstock)

New Risk-Stratification Tool Predicts Relapse After Blinatumomab in Childhood ALL

Acute lymphoblastic leukemia in children and young people requires careful assessment of relapse risk, particularly as treatment approaches move beyond standard chemotherapy. Traditional relapse predictors... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Decentralized Laboratory Network Improves Detection of Viral Hemorrhagic Fevers in Guinea

Viral hemorrhagic fevers remain a major diagnostic challenge in West Africa because their early symptoms can resemble those of other febrile illnesses. The 2014–2016 Ebola epidemic underscored the need... Read more

Pathology

view channel
Image Credit: Adobe Stock

AI Pathology Approach Closely Aligns With Breast Cancer Genomic Risk Classification

In early-stage breast cancer, precision oncology relies on biological information to guide personalized treatment decisions. Because access to tissue-based genomic testing may be limited, there is growing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.